2/28/2025SciClone Secures Rights to Eisai's Tasurgratinib for Greater China

2/28/2025Henlius Initiates Phase 1b/2 Trial for PD-L1 ADC HLX43 in Solid Tumors

2/28/2025Recent Executive Moves

2/28/2025CDE Seeks Public Feedback on "SPARK Initiative" to Boost Pediatric Onc...

2/28/2025NMPA Approves Multiple Drugs for Cancer, Cardiovascular, and Liver Dis...

2/28/2025Duality Biologics Withdraws Hong Kong IPO Plans Amidst Strategic Partn...

2/27/2025Takeda Expands Partnership with BridGene to Tackle Hard-to-Drug Target...

2/27/2025Novartis' NDA for BTK Inhibitor Remibrutinib Accepted by NMPA

2/27/2025Akeso Initiates First-in-Human Phase 1 Trial for HER3-Targeting ADC AK...

2/27/2025Biokin (SystImmune) Initiates First Autoimmune Clinical Trial for Tetr...

2/27/2025Henlius Registers Phase 3 Trials for Keytruda and Yervoy Biosimilars

2/27/2025HBM Alpha Enters License Deal to Advance Novel Endocrine Therapies

2/27/2025IVIEW Thera Reports Positive Phase 1/2 Results for IVW-1001 Ophthalmic...

2/26/2025Hengrui Reports Promising Results for Trastuzumab Rezetecan in HER2-Mu...

2/26/2025YolTech Therapeutics Announces Positive Clinical Data for In Vivo Gene...

2/26/2025Former NMPA Deputy Commissioner Under Investigation

2/26/2025In Vivo Gene Editing Product ART002 Achieves Saturation of Pharmacolog...

2/25/2025BioCity's SC0062 Achieves Primary Endpoint in Phase 2 DKD Trial

2/25/2025Ardelyx/Fosun'sTenapanor Approved for Hyperphosphatemia in CKD Dialysi...

2/25/2025China Launches Flagship Hospital Alliance to Advance Integrative Medic...

2/25/2025OS Therapies Launches Subsidiary to Seek ADC Joint Ventures in US and ...

2/25/2025Pfizer to Study China-Originated Ivonescimab in ADC Combo Under Summit...

2/25/2025Innovent's Dual Immunotherapy for Colon Cancer Advances with NMPA Prio...

2/25/2025XellSmart Secures Second FDA IND Approval for iPSC-Derived ALS Therapy...

2/21/2025Recent Executive Moves

2/21/2025Hengrui Medicine Advances Dual GLP-1/GIP Agonist HRS9531 with First Ph...

2/21/2025MediLink's YL217 Received FDA Clearance of IND Application

2/21/2025NMPA Announces Package Insert Revision of Fluorouracil Injection

2/21/2025Novo Nordisk Sues KBP Biosciences for $830 Million Over Alleged Fraud

2/21/2025India Can Surpass China in Drug Discovery, Says Biocon Chief

Page:25/55 Total number of articles:1623: [First][<<] [23] [24] [25] [26] [27] [>>] [End]